Advice to persons with diabetes considering use of complementary therapies:
- Inform your health care team of complementary therapy use.
- Individuals who are considering use are likely to be actively involved in their health care and should be commended for their interest.
- Work in partnership with your health care team since complementary therapies are not benign, they may have side effects and may interact with other diseases, drugs, nutrients, or even other complementary therapies.
- These products should not be substituted for essential diabetes care such as meal planning, physical activity, and medications.
- "Natural" does not mean "safe."
- These products are not subject to rigorous government safety and efficacy testing and may contain contaminants or other ingredients that are toxic.
- Look for telephone numbers and addresses on labels of products and ask many, many questions. Do a background research on a product before taking it - ask the manufacturer for research and published information.
- Whenever possible, purchase products that are standardized and buy from companies that invest in research and meet "Good Manufacturing Practice" (GMP) guidelines. This may ensure product purity and safety.
Complementary and Alternative Medicine Pages:
Main | Concerns | Gymnema Sylvestre | Fenugreek | Bitter Melon | Ginseng | Nopal | Aloe, Bilberry, and Milk Thistle | Chromium | Vanadium | CoQ10 | Nicotinamide | Alpha Lipoic Acid | Gamma Linolenic Acid | Ginkgo Biloba | Garlic | Advice | Additional Reading | References
Laura Shane-McWhorter, PharmD, BCPS, FASCP, CDE, BC-ADM
November 24, 2001
Last Updated: Friday August 30, 2002 10:33:14
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.